论文部分内容阅读
目的评价国产Partner冠状动脉支架治疗冠心病的安全性和疗效。方法回顾性分析在21个心脏中心置入Partner冠状动脉支架的1 352例冠心病患者,观察术后1年内心源性死亡、心肌梗死、靶血管重建率、主要不良心脏事件(MACE)和支架内血栓形成发生率。结果1 352位患者共1 869处病变置入Partner支架。其中,糖尿病患者占23.3%,急性冠状动脉综合征的患者占90.49%,C型病变占30.98%,分叉病变占11.13%,慢性完全闭塞病变占7.81%;靶病变血管平均长度21.99±10.57 mm,病变平均狭窄程度88.18%±10.93%,参考血管直径3.17±1.81 mm,病变最大扩张压力13.77±3.01 atm;使用球囊预扩张的病变占78.12%,球囊后扩张的病变占25.79%。随访结果显示:12个月累积心源性死亡0.52%,心肌梗死0.96%,靶血管重建2.14%,MACE3.62%,数据均在可接受范围内。患者1年累积血栓发生率(0.66%)与其他研究结果类似。结论1年的随访结果表明,国产Partner冠状动脉支架的安全性和有效性良好。
Objective To evaluate the safety and efficacy of domestic-made Partner Coronary Stent in the treatment of coronary heart disease. Methods A total of 1 352 coronary heart disease patients with Partner Coronary Stent were enrolled in 21 heart centers. The incidences of cardiac death, myocardial infarction, target vessel revascularization, major adverse cardiac events (MACE) and stents The incidence of thrombosis. Results A total of 1 869 lesions were placed on the Partner Stent in 1 352 patients. Among them, diabetes accounted for 23.3%, patients with acute coronary syndrome accounted for 90.49%, C-type lesions accounted for 30.98%, bifurcation lesions accounted for 11.13%, chronic occlusive lesions accounted for 7.81%; target lesion average length of 21.99 ± 10.57 mm , The average degree of stenosis was 88.18% ± 10.93%, the reference blood vessel diameter was 3.17 ± 1.81 mm, the maximum expansion pressure of the lesion was 13.77 ± 3.01 atm; the lesions pre-dilated with balloon accounted for 78.12% and the posterior balloon-dilated lesions accounted for 25.79%. The follow-up results showed that: the cumulative cardiac death 0.52%, myocardial infarction 0.96%, target vessel reconstruction 2.14% and MACE 3.62% at 12 months, the data were within the acceptable range. One-year cumulative incidence of thrombosis (0.66%) was similar to other studies. Conclusions The 1-year follow-up results show that the safety and efficacy of domestic-made coronary stent are good.